An investigation into the presence of a vagal tachycardia and the effect of vasoactive intestinal polypeptide on rat heart rate in vitro

Pharmacology

Volumn 76, Issue 2, 2006, Pages 101-104

  Hogan, K ^a   Markos, F ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Tachycardia; Vagus; Vasoactive intestinal polypeptide

Indexed keywords

ATENOLOL; ATROPINE; NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; HEART ATRIUM; HEART INNERVATION; HEART RATE; IN VITRO STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; RAT; TACHYCARDIA; VAGUS NERVE; VAGUS NERVE STIMULATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATENOLOL; ATROPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HEART ATRIA; HEART RATE; RATS; TACHYCARDIA; VAGUS NERVE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 31144452476     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090500     Document Type: Article

References (16)

1. Hill MR, Wallick DW, Mongeon LR, Martin PJ, Levy MN: Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog. Am J Physiol 1995;269:H1467-H1472.
2. Hill MR, Wallick DW, Martin PJ, Levy MN: Frequency dependence of vasoactive intestinal polypeptide release and vagally induced tachycardia in the canine heart. J Auton Nerv Syst 1993;43:117-122.
3. Henning RJ, Feliciano L, Coers CM: Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate. Cardiovasc Res 1996;32:846-853.
4. Markos F, Snow HM: The potentiation of sinus arrhythmia by vasoactive intestinal polypeptide (VIP) in the anaesthetized dog. Neuropeptides 2001;35:238-243.
5. O'Leary DM, Jones JF: Discharge patterns of preganglionic neurones with axons in a cardiac vagal branch in the rat. Exp Physiol 2003;88:711-723.
6. Sweeney C, Markos F: The role of neuronal nitric oxide (NO) in the vagal control of cardiac interval of the rat heart in vitro. Auton Neurosci 2004;111:110-115.
7. Markos F, Snow HM: Potentiation of vagally mediated tachycardia by atropine in the anaesthetized dog. J Physiol 1997;504:194P.
8. Shvilkin A, Danilo P Jr, Chevalier P, Chang F, Cohen IS, Rosen MR: Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart. Cardiovasc Res 1994;28:1769-1773.
9. Rigel DF: Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT. Am J Physiol 1988;255:H311-H317.
10. Roossien A, Brunsting JR, Nijmeijer A, Zaagsma J, Zijlstra WG: Effects of vasoactive intestinal polypeptide on heart rate in relation to vagal cardioacceleration in conscious dogs. Cardiovasc Res 1997;33:392-399.
11. Hoover DB: Effects of guinea pig vasoactive intestinal peptide on the isolated perfused guinea pig heart. Peptides 1989;10:343-347.
12. Ruane T, Snow M, Markos F, Hall WJ: A comparative study of the heart rate responses to vagal stimulation in the pharmacologically denervated heart of the mini-pig and the dog. J Physiol 1997;501:69P.
13. Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK: Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br J Pharmacol 1996;119:423-431.
14. Conlon K, Kidd C: Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. J Auton Nerv Syst 1999; 75:136-146.
15. Richardson RJ, Grkovic I, Anderson CR: Immunohistochemical analysis of intracardiac ganglia of the rat heart. Cell Tissue Res 2003; 314:337-350.
16. Sawmiller DR, Henning RJ, Cuevas J, Dehaven WI, Vesely DL: Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart. Neuropeptides 2001;38:289-297.